Delivery Order SPE2DR25D3111-SPE2DR26FF3YV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,082.10 to AmerisourceBergen Drug Corp for the supply of Restasis 0.05% Eye Emulsion (60 count) on January 22, 2026, with an ultimate completion date of January 23, 2026. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office, with performance to be fulfilled from the company's Conshohocken, Pennsylvania location. The award falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,013.75 to AmerisourceBergen Drug Corp for Restasis 0.05% eye emulsion (30 single-use vials) on January 8, 2026, with an ultimate completion date of January 9, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. AmerisourceBergen Drug Corp operates as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Restasis 0.05% Eye Emulsion in 30-count units, with a contract ceiling value of $2,707.19 and an ultimate completion date of November 10, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,923.36 to AmerisourceBergen Drug Corp for the supply of Restasis 0.05% Eye Emulsion (60 units) on January 16, 2026, with an ultimate completion date of January 20, 2026. This is a firm fixed-price, non-set-aside contract with performance taking place in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc., which holds a significant indefinite delivery contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,340.35 to AmerisourceBergen Drug Corp for supply of Restasis 0.05% Eye Emulsion (60 count) on January 15, 2026, with a completion date of January 16, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a $4,871.29 delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (30 single-dose units) on December 17, 2025, with an ultimate completion date of December 18, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle...
- The Defense Logistics Agency awarded a $3,561.92 delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (30-count) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $18,986.97 to AmerisourceBergen Drug Corp for the supply of Restasis 0.05% Eye Emulsion (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical distributors....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of RESTASIS 0.05% Eye Emulsion in 60-count units. This is a competitively awarded, firm fixed-price delivery order valued at $1,862.70 with no set-aside designation, with an ultimate completion date of July 23, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,256.45 delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% eye emulsion (30-unit pack) on November 28, 2025, with completion targeted for December 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The contractor will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- SPE2DR25D3111Indefinite Delivery Contract
- SPE2DR25D3111-SPE2DR26FF3YVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp on January 22, 2026, for the supply of Restasis 0.05% Eye Emulsion in 30-unit quantities, with a ceiling value of $1,261.89 and an ultimate completion date of January 23, 2026. This award represents a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerSourceBergen Drug Corp's corporate headquarters. The order falls under a larger Indefinite Delivery Contract (IDC) vehicle—the DLA Troop Support Medical contract valued at up to $999,999,999.00 through December 2026—which enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc. (which operates under the AmerSourceBergen name), is a major pharmaceutical distributor and critical federal vendor serving the Defense Logistics Agency and other government healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to supply medications across multiple therapeutic domains, including specialty pharmaceuticals, vaccines, medical devices, and generic drugs. This particular delivery order for ophthalmic medication supports the broader federal medical procurement mission, ensuring pharmaceutical supplies are available to military treatment facilities and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/21/26 |